Gavestinel sodium

CAS No. 153436-38-5

Gavestinel sodium( —— )

Catalog No. M33855 CAS No. 153436-38-5

Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 Get Quote
5MG 85 Get Quote
10MG 140 Get Quote
25MG 228 Get Quote
50MG 339 Get Quote
100MG 489 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Gavestinel sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.
  • Description
    Gavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR | NMDAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    153436-38-5
  • Formula Weight
    397.19
  • Molecular Formula
    C18H11Cl2N2NaO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (251.77 mM; Ultrasonic )
  • SMILES
    O=C(NC1=CC=CC=C1)/C=C/C2=C(C([O-])=O)NC3=CC(Cl)=CC(Cl)=C23.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fabio RD, et, al. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem. 1997 Mar 14;40(6):841-50.?
molnova catalog
related products
  • Rislenemdaz hydrochl...

    Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.

  • Sunifiram

    Sunifiram is a potent nootropic agent.

  • CGP 37849

    CGP 37849 is a competitive orally active N-methyl-D-aspartate (NMDA) receptor antagonist ((Ki = 35 nM)) with potency.CGP 37849 is an anticonvulsant in rodents and also has antidepressant and anxiolytic properties.